Contact Us

Press | Convergent Dental


Drs. David Fantarella and Jeffrey Rohde Perform Live Procedures with Convergent Dental’s 9.3 Micron CO2 Dental Laser Solea at Yankee Dental Congress 2016

Boston, MA — January 20, 2016 – Convergent Dental, Inc., a privately held dental device company, announced that Drs. David Fantarella and Jeffrey Rohde will be performing live procedures using Solea, the world’s first computer-aided, CO2 laser system to ever be cleared by the FDA for hard, soft and osseous tissue indications, at the Yankee Dental Congress taking place from January 27-31 at the Boston Convention and Exhibition Center in Boston, MA.

Who: Dr. David Fantarella, DMD and Dr. Jeffrey Rohde, DDS

What: Drs. Fantarella and Rohde will be performing live procedures anesthesia-free and blood-free with Solea at the Yankee Dental Congress. This first-hand look at the top-selling hard and soft tissue dental laser in North America is available to all Yankee Dental Congress attendees.

Solea is reliably anesthesia-free and blood-free for the majority of hard and soft tissue procedures while also delivering quick healing and minimal post-operative discomfort. These combined attributes enable efficiency gains from virtually eliminating anesthesia, adding new procedures like soft tissue surgeries and increased new patient volume from improved patient experiences. Audience members will have the opportunity to see the dentists perform a wide variety of procedures while also having an opportunity to ask Drs. Fantarella and Rohde and their patients’ questions about Solea during the presentation.

When: Friday, January 29, 2016 at 10:00 a.m. to 12:00 p.m.

“Seeing is believing in dentistry, so we wanted to provide Yankee Dental Congress attendees with a look at Solea in action with real patients,” said Michael Cataldo, CEO of Convergent Dental. “Solea is able to perform hard and soft tissue procedures that are reliably anesthesia-free, blood-free, suture-free, and pain-free because of its unique wavelength and computer controls. Drs. Fantarella and Rohde will be showcasing these features and so much more during the presentation.”

Practitioners interested in learning more about Solea can email or call 1-844-GO-SOLEA.

# # #

About Convergent Dental, Inc.

Convergent Dental, Inc., is a privately owned dental equipment and technology company. We are the developer of Solea®, the first computer-aided, CO2 laser system to be cleared by the FDA for hard, soft, and osseous tissue indications. With Solea’s unique wavelength and computer controls, dentists can reliably perform procedures anesthesia-free, blood-free, suture-free, and pain-free. For dentists, reliably anesthesia-free and blood free procedures are powerful practice growth drivers which enables multi-quadrant dentistry, saves time overall, allows dentists to perform more procedures themselves rather than refer patients out, and provides a more positive patient experience. For more information, follow the company on Twitter, Facebook, LinkedIn, and Instagram.

Convergent Dental Brings in $40M to Forever Change How ...

Needham, MA, – Convergent Dental, developer of Solea®, the world’s first laser to enable reliably anesthesia-...

1 min read

Solea All-Tissue Laser Reduces Dental Aerosols & Splatt...

Needham, MA – Convergent Dental, Inc., developer of the industry-leading 9.3µm CO2 all-tissue Solea laser, an...

1 min read

Request More Information